| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754051A1 Therapeutic agent for disorder of lipid metabolism |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
| 01/22/1997 | EP0549581B1 Framework mutated antibodies and their preparation |
| 01/22/1997 | EP0546007B1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
| 01/22/1997 | EP0544802B1 Methods and compositions for treating t-cell mediated diseases |
| 01/22/1997 | EP0531401B1 Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells |
| 01/22/1997 | EP0528858B1 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 01/22/1997 | EP0524971B1 Decontaminated biological material |
| 01/22/1997 | EP0500659B1 Monoclonal antibodies |
| 01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
| 01/22/1997 | CN1141061A Thrombopoietin |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
| 01/22/1997 | CN1141002A Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1140609A Medicament for nasal administration |
| 01/22/1997 | CN1140588A "Shuganmei" medicine for treatment of liver disease and its preparation |
| 01/22/1997 | CN1033865C Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |
| 01/21/1997 | US5596090 Treatment of septic shock, adult respiratory distress syndrome |
| 01/21/1997 | US5596088 DNA Encoding the human P2U receptor and null cells expressing P2U receptors |
| 01/21/1997 | US5596081 Antibodies and atp or gtp |
| 01/21/1997 | US5596079 Mimetics of senescent cell derived inhibitors of DNA synthesis |
| 01/21/1997 | US5596078 Synthesis of cyclic peptides |
| 01/21/1997 | US5596072 Method of refolding human IL-13 |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5596000 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 01/21/1997 | US5595990 Treatment of cardiovascular disorders |
| 01/21/1997 | US5595978 Composition and method for treatment of CMV retinites |
| 01/21/1997 | US5595977 Bactericides as antiulcer agents |
| 01/21/1997 | US5595974 Batroxobin with heparin for cardiovascular disorders |
| 01/21/1997 | US5595973 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 01/21/1997 | US5595972 Polypeptides for signals |
| 01/21/1997 | US5595971 Prolonged release of biologically active polypeptides |
| 01/21/1997 | US5595969 Complexed with antiinflammatory agent, drug delivery |
| 01/21/1997 | US5595903 Expression vectors, host cells |
| 01/21/1997 | US5595902 DNA encoding human protein kinase C (iota) |
| 01/21/1997 | US5595898 Cdna genetic sequences |
| 01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
| 01/21/1997 | US5595886 Gene expression in eukaryotic cell, treatment of hemophilia |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595884 Papillomavirus E2 transactivation repressor proteins and DNA |
| 01/21/1997 | US5595880 DNA encoding an α2B adrenergic receptor and uses thereof |
| 01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
| 01/21/1997 | US5595873 T. thermophila group I introns that cleave amide bonds |
| 01/21/1997 | US5595872 Dna sequences, cells and expression vectors |
| 01/21/1997 | US5595760 Sustained release of peptides from pharmaceutical compositions |
| 01/21/1997 | US5595752 Increasing dressing percentage and carcass weight in finishing beef cattle |
| 01/21/1997 | US5595743 Preparation of herbal medicines by using a multi-enzyme system, herbal medicines prepared and their uses |
| 01/21/1997 | US5595737 Leukocyte adhesion molecule, distinction between bound and shed molecule |
| 01/21/1997 | US5595736 Compounds and methods for treatment of thromboembolic disorders |
| 01/21/1997 | US5595735 Hemostatic thrombin paste composition |
| 01/21/1997 | US5595734 Compositions comprising ONCONASE (tm) and lovastatin |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/21/1997 | US5595721 Using antibodies directed to an antigen and radioactive labels |
| 01/21/1997 | CA2097821C Ganoderma lucidum iy009 which produces proteoglycan(g009) having effect of enhancing antitumor immunity |
| 01/21/1997 | CA2037831C Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host disease |
| 01/21/1997 | CA2033249C Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures |
| 01/21/1997 | CA1338860C Radiolabelling of proteins |
| 01/20/1997 | CA2181308A1 Improving the tolerability of pharmaceutically active beta-amino acids |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001635A1 Bax omega protein and methods |
| 01/16/1997 | WO1997001634A2 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 01/16/1997 | WO1997001633A1 Cytokine that induces apoptosis |
| 01/16/1997 | WO1997001630A1 HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001578A1 Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides |
| 01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/16/1997 | WO1997001575A1 Substance wf16616, process for production thereof, and use thereof |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | WO1997001351A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | WO1997001349A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 01/16/1997 | WO1997001336A1 Use of lamellarin-class alkaloids in methods of treatment |
| 01/16/1997 | WO1997001331A2 Method of producing sustained-release preparation |
| 01/16/1997 | WO1997001275A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | WO1996037610A3 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
| 01/16/1997 | WO1996037607A3 Nucleic acid with a polymorphic domain of a b2 bradykinin receptor gene |
| 01/16/1997 | WO1996034887A3 Antisense peptides |
| 01/16/1997 | WO1996034113A3 Methods for the identification of farnesyltransferase inhibitors |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19627392A1 Medikament zur Verabreichung durch die Nase Medication to be administered through the nose |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2225255A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | CA2224701A1 Bax omega protein and methods |
| 01/16/1997 | CA2224381A1 Method of producing sustained-release preparation |
| 01/16/1997 | CA2224319A1 Human glandular kallikrein-1 (hk2) |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/16/1997 | CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |